211 related articles for article (PubMed ID: 31040676)
1. Anti-N-methyl-D-aspartate receptor encephalitis mimics neuroleptic malignant syndrome: case report and literature review.
Wang HY; Li T; Li XL; Zhang XX; Yan ZR; Xu Y
Neuropsychiatr Dis Treat; 2019; 15():773-778. PubMed ID: 31040676
[TBL] [Abstract][Full Text] [Related]
2. Examining the Features of Neuroleptic Malignant Syndrome in Anti-NMDA Receptor Encephalitis: A Case-Control Study.
Ramirez-Bermudez J; Restrepo-Martinez M; Espinola-Nadurille M; Martinez-Angeles V; Lopez-Hernandez JC; Hernandez-Vanegas LE; Martinez-Carrillo F; Ruiz-Garcia R; Rivas-Alonso V; Flores-Rivera J; Pollak TA
J Acad Consult Liaison Psychiatry; 2024; 65(3):222-230. PubMed ID: 38151160
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic Malignant Syndrome in a Patient With Anti-N-Methyl-D-Aspartate Receptor Encephalitis: Case Report and Review of Related Literature.
Sarmiento RJC; Diestro JDB; Antonio AKD; Prado MB; Adiao KJB; Dioquino-Maligaso CP
Neurohospitalist; 2022 Jan; 12(1):80-85. PubMed ID: 34950391
[TBL] [Abstract][Full Text] [Related]
4. Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Potential Mimic of Neuroleptic Malignant Syndrome.
Rozier M; Morita D; King M
Pediatr Neurol; 2016 Oct; 63():71-72. PubMed ID: 27590992
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and therapeutic challenges in neuroleptic malignant syndrome: a severe medical case.
Brogna P; Colasuonno R; Di Michele F; Paterniti AM; Talamo A; Ribolsi M; Jannini TB; Siracusano A; Niolu C
Riv Psichiatr; 2020; 55(4):236-239. PubMed ID: 32724236
[TBL] [Abstract][Full Text] [Related]
6. Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis: an etiology worth considering in the differential diagnosis of delirium.
Punja M; Pomerleau AC; Devlin JJ; Morgan BW; Schier JG; Schwartz MD
Clin Toxicol (Phila); 2013; 51(8):794-7. PubMed ID: 23962100
[TBL] [Abstract][Full Text] [Related]
7. Thymic Hyperplasia-Associated Autoimmune Encephalitis Mimicking Neuroleptic Malignant Syndrome: A Case Report.
Abu-Abaa M; Pylypiv H; Abdulsahib A; Ali D
Cureus; 2022 Nov; 14(11):e31186. PubMed ID: 36505172
[TBL] [Abstract][Full Text] [Related]
8. Agitation Management in Pediatric Males with Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Schumacher LT; Mann AP; MacKenzie JG
J Child Adolesc Psychopharmacol; 2016 Dec; 26(10):939-943. PubMed ID: 27992257
[TBL] [Abstract][Full Text] [Related]
9. Refining the psychiatric syndrome of anti-N-methyl-d-aspartate receptor encephalitis.
Warren N; Siskind D; O'Gorman C
Acta Psychiatr Scand; 2018 Nov; 138(5):401-408. PubMed ID: 29992532
[TBL] [Abstract][Full Text] [Related]
10. A case report of anti-NMDA receptor encephalitis in a 23-year-old female with acute psychiatric symptoms.
Khatrawi EM; Prajjwal P; Marsool MDM; Das A; Nagre A; Inban P; Marsool ADM; Hussin OA
Clin Case Rep; 2024 May; 12(5):e8870. PubMed ID: 38721553
[TBL] [Abstract][Full Text] [Related]
11. Neuroleptic intolerance in the context of anti-N-methyl-D-aspartate receptor encephalitis: A systematic review and synthesis of global case reports.
Pacheco-Barrios K; Navarro-Flores A; de Melo PS; Rebello-Sanchez I; Parente J; Asenjo ED; Gordillo I; Zeña-Ñañez S; Failoc-Rojas VE
Acta Neurol Scand; 2022 Nov; 146(5):410-428. PubMed ID: 36086808
[TBL] [Abstract][Full Text] [Related]
12. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
Khouri C; Planès S; Logerot S; Villier C; Mallaret M
Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
[TBL] [Abstract][Full Text] [Related]
13. Anti-NMDA receptor encephalitis and overlapping demyelinating disorder in a 20-year old female with borderline personality disorder: proposal of a diagnostic and therapeutic algorithm for autoimmune encephalitis in psychiatric patients "case report".
Weiss D; Kertzscher L; Degering M; Wozniak D; Kluge M
BMC Psychiatry; 2021 Jul; 21(1):355. PubMed ID: 34266413
[TBL] [Abstract][Full Text] [Related]
14. Atypical presentation of anti-N-methyl-D-aspartate receptor encephalitis: two case reports.
Maggio MC; Mastrangelo G; Skabar A; Ventura A; Carrozzi M; Santangelo G; Vanadia F; Corsello G; Cimaz R
J Med Case Rep; 2017 Aug; 11(1):225. PubMed ID: 28810906
[TBL] [Abstract][Full Text] [Related]
15. Severe Recurrence of Neuroleptic Malignant Syndrome: Usefulness of Dexmedetomidine for Antipsychotic Withdrawal.
Maeda K; Ichiba T; Kashiwa K; Okazaki Y
Cureus; 2023 Oct; 15(10):e47088. PubMed ID: 38022067
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of anti-N-methyl-D-aspartate receptor encephalitis in patients with a long-term history of mental disorders.
Wang HY; Yang XY; Han J; Liu H; Yan ZR; Liang Z
Eur J Med Res; 2022 Mar; 27(1):38. PubMed ID: 35272706
[TBL] [Abstract][Full Text] [Related]
17. Frequency and temporal sequence of clinical features in adults with anti-NMDA receptor encephalitis presenting with psychiatric symptoms.
Gurrera RJ
Psychol Med; 2019 Dec; 49(16):2709-2716. PubMed ID: 30560745
[TBL] [Abstract][Full Text] [Related]
18. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.
Musselman ME; Browning LA; Parker D; Saely S
Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252
[TBL] [Abstract][Full Text] [Related]
19. Psychiatric Presentation of Anti-NMDA Receptor Encephalitis.
Endres D; Rauer S; Kern W; Venhoff N; Maier SJ; Runge K; Süß P; Feige B; Nickel K; Heidt T; Domschke K; Egger K; Prüss H; Meyer PT; Tebartz van Elst L
Front Neurol; 2019; 10():1086. PubMed ID: 31749755
[No Abstract] [Full Text] [Related]
20. Neuroleptic malignant syndrome: a concealed diagnosis with multitreatment approach.
Velosa A; Neves A; Barahona-Corrêa JB; Oliveira-Maia AJ
BMJ Case Rep; 2019 Jun; 12(6):. PubMed ID: 31213433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
